---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025182"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:36:57.515497+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma files updated auditor consents for S-3 registration

## Summary
- Filed updated consents from former auditor KMJ Corbin and current auditor Crowe LLP, dated Nov 26, 2025.
- Consents relate to audit reports on FY2024 financials included in Form 10-K filed Mar 25, 2025.
- Consents are for incorporation into Registration Statement on Form S-3 (No. 333-290725).

## SEC filing metadata
- accession: 0001493152-25-025182
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/0001493152-25-025182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025182
- JSON: https://secwatch.observer/filing/0001493152-25-025182.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.